hero section gradient
15 handpicked stocks

Political Donors: Team Red

This collection showcases companies with significant financial ties to the Republican party. These carefully selected stocks, primarily from energy and industrial sectors, may benefit from favorable legislation if their supported political agenda succeeds.

Author avatar

Han Tan | Market Analyst

Published on June 17

Your Basket's Financial Footprint

Concise analysis of the basket's total market capitalisation and concentration among top constituents.

Key Takeaways for Investors:
  • Large cap dominance generally implies lower volatility, greater stability and returns that tend to track the broader market.
  • Suitable as a core holding, offering broad exposure rather than a speculative, tactical growth position.
  • Likely to deliver steady long-term value rather than explosive short-term gains.
Total Market Cap
  • XOM: $480.51B

  • CVX: $314.87B

  • COP: $107.92B

  • Other

About This Group of Stocks

1

Our Expert Thinking

These companies share a history of supporting Republican candidates and causes through corporate donations and PACs. Their business interests often align with Republican policy priorities like deregulation, reduced corporate taxes, and energy independence.

2

What You Need to Know

This collection focuses heavily on energy and industrial stocks, particularly in oil, gas, and manufacturing. These sectors tend to be cyclical and may perform differently based on which political party controls government policy and regulation.

3

Why These Stocks

Each company was selected based on public records of political contributions and their alignment with Republican policy goals. They represent established firms whose business operations could benefit from Republican-led initiatives, especially during election cycles.

Why You'll Want to Watch These Stocks

🗳️

Election Cycle Opportunity

As election season approaches, these companies could benefit from increased visibility and potential policy shifts favoring their industries. Political momentum often creates market movement.

Energy Policy Winners

Many of these stocks are positioned in fossil fuel and energy infrastructure sectors that historically benefit from Republican-led regulatory changes and energy independence initiatives.

📊

Political Alignment Strategy

By understanding which companies support specific political agendas, you gain insight into potential beneficiaries of future policy shifts. This could be particularly valuable during political transitions.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Tech Stocks (AI Valuation Reset) Present Potential Entry

Tech Stocks (AI Valuation Reset) Present Potential Entry

Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.

Walmart Succession Plan Explained | Market Effects

Walmart Succession Plan Explained | Market Effects

Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.

Biotech Buyout Candidates (Post-Merck Acquisition)

Biotech Buyout Candidates (Post-Merck Acquisition)

Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.

Frequently Asked Questions